![]()
HANGZHOU, ZHEJIANG, CHINA, September 24, 2026 /EINPresswire.com/ —
As demand for efficient animal health monitoring continues to grow across farms, veterinary clinics, laboratories, and animal health supply chains, Hangzhou HEO Technology Co., Ltd. is expanding its role as a veterinary test manufacturer with a broader portfolio of rapid diagnostic solutions. Founded in 2011, the Hangzhou-based company focuses on in vitro diagnostic products, point-of-care testing reagents, food safety diagnostics, and veterinary products designed for companion animals and farm animals. Its business reflects the increasing importance of accessible testing technologies in modern animal healthcare and disease management.
Veterinary diagnostics have become an increasingly important component of livestock production and companion animal care. Early identification of infectious diseases can support veterinary professionals, farm managers, and animal owners in making timely decisions about isolation, treatment, monitoring, and further laboratory analysis. Rapid test formats can be particularly useful in settings where immediate preliminary information is needed and access to large laboratory facilities may be limited.
Against this industry background, Hangzhou HEO Technology Co., Ltd. has developed a portfolio covering multiple categories of veterinary testing. Its veterinary product range includes testing solutions for swine, poultry, ruminants, dogs, and cats. The company’s website also identifies applications in breeding plants, farms, laboratories, pet shops, veterinary clinics, and veterinary hospitals. This broad application structure allows rapid testing technologies to serve different points across the animal health ecosystem.
The company’s veterinary portfolio includes products addressing a range of infectious diseases and veterinary diagnostic needs. Among its offerings are swine test kits, avian test kits, ruminant test kits, and canine and feline test kits. Publicly listed examples include tests for African swine fever, porcine diseases, avian influenza, avian infectious diseases, bovine brucellosis, canine heartworm, feline leukemia virus, feline immunodeficiency virus, feline panleukopenia, and other conditions. Such product diversity illustrates the role of rapid diagnostics in supporting different animal species and production environments.
For livestock producers, veterinary testing can be closely connected with biosecurity. Disease outbreaks can affect animal welfare, production efficiency, trade, and supply continuity. Rapid screening tools can provide preliminary information that helps professionals determine whether additional investigation or laboratory confirmation may be appropriate. In this context, veterinary test manufacturers are increasingly expected to provide not only individual test kits but also product portfolios that can support different disease-monitoring scenarios.
Hangzhou HEO Technology Co., Ltd. has positioned its product development around this broader diagnostic requirement. According to its public company information, HEO operates research and development activities alongside standardized production facilities and has established a product portfolio of more than 100 types. The company states that its business covers more than 100 countries and regions, reflecting an international orientation in the development and distribution of diagnostic products.
The company’s activities also extend beyond veterinary diagnostics. Its Food Safety Test portfolio addresses another area closely connected with animal production and public health. Food safety testing can help identify certain contaminants, residues, or other target substances in food-related samples. HEO publicly lists rapid test products covering substances such as aflatoxins, tetracyclines, sulfonamides, amantadine, cyromazine, nicarbazin, and other targets. Its food safety materials describe applications involving products such as milk, meat, eggs, grains, fruits, and vegetables.
The connection between veterinary health and food safety is particularly significant in livestock and poultry production. Animal health problems, veterinary drug residues, and food contamination can create challenges that extend beyond individual farms. Testing technologies therefore have a role in supporting monitoring programs throughout agricultural and food supply chains. By maintaining veterinary and food safety diagnostic categories within the same business, HEO Technology participates in several stages of this broader testing environment.
Another important part of the company’s portfolio is Human Test. The Human Test category includes products covering infectious diseases, respiratory conditions, hormones, drugs of abuse, tumor and cardiac markers, and semi-quantitative testing. Publicly listed products include rapid tests for HIV, influenza and COVID-19 combinations, typhoid, chlamydia, vitamin D, TSH, HbA1c, and other testing applications.
The combination of veterinary, food safety, and human diagnostic products demonstrates the company’s broader focus on rapid testing technology. Although these categories address different end users and testing scenarios, they share an emphasis on diagnostic accessibility, standardized manufacturing, product development, and quality management. For international distributors and professional users, a diversified product portfolio can also provide opportunities to source multiple types of rapid diagnostic products from a single manufacturer.
Quality management is another factor shaping the rapid diagnostic industry. Diagnostic products must be manufactured under controlled processes because consistency can directly affect their intended testing performance. Hangzhou HEO Technology Co., Ltd. states that its products are manufactured under ISO 9001:2015 and ISO 13485:2016 quality management systems. Its public certification information also lists ISO 14001 and ISO 45001, together with CE certification and other certificates or approvals associated with specific markets and products.
HEO’s certification information also identifies a China Ministry of Agriculture and Rural Affairs certificate associated with its African Swine Fever virus rapid test kit. The company further states that it maintains GMP-related production facilities. These quality and regulatory elements are relevant to international buyers because requirements for diagnostic products can vary substantially between markets and applications. Product-specific regulatory status should therefore be assessed according to the intended country, product, and use case.
Research and development remains another area of attention for the company. The manufacturer describes its R&D team as a key part of its business development strategy and states that it continues to develop new products according to market requirements. Its publicly listed portfolio is periodically expanded with new veterinary and diagnostic products, reflecting the changing needs of animal health professionals and testing markets.
The practical design of rapid test kits is also important for decentralized testing environments. Veterinary clinics, farms, breeding operations, and other users may require testing products that can be handled efficiently without complex laboratory infrastructure. Product formats such as rapid test cassettes and related components are therefore increasingly visible across veterinary diagnostic portfolios. HEO’s veterinary product pages include test cassettes supplied with components such as swabs, buffers, droppers, and instructions, depending on the specific product.
For distributors, the ability to customize and support different market requirements can also influence supplier selection. HEO’s public product information indicates that OEM and ODM services are available, allowing certain products and packaging solutions to be adapted according to customer requirements. The company also states that its products can be customized and that it provides services for end customers and channel partners.
The global veterinary diagnostics market continues to evolve alongside changes in livestock production, companion animal healthcare, international trade, and disease surveillance. For manufacturers, this creates opportunities as well as responsibilities. Buyers increasingly require dependable supply, appropriate documentation, consistent production, and product portfolios that can address diverse animal health challenges.
Within this environment, Hangzhou HEO Technology Co., Ltd. continues to build its position around rapid diagnostic products for veterinary, food safety, and human testing applications. Its combination of product development, manufacturing capabilities, quality management systems, and international distribution provides a foundation for serving different diagnostic markets. The company’s presence across more than 100 countries and regions, as stated on its official website, also demonstrates the international scope of its commercial activities.
As veterinary medicine becomes increasingly focused on earlier detection, disease surveillance, and practical testing workflows, rapid diagnostic technologies are expected to remain an important part of the industry’s development. Manufacturers with experience across multiple diagnostic categories can contribute to this shift by developing products that address the operational requirements of farms, clinics, laboratories, distributors, and other professional users.
About Hangzhou HEO Technology Co., Ltd.
Hangzhou HEO Technology Co., Ltd. was founded in 2011 and is a high-tech enterprise specializing in animal in vitro diagnostic materials, point-of-care testing diagnostic reagents, food safety diagnostic products, and veterinary products for companion and farm animals. Based in Yuhang District, Hangzhou, Zhejiang, China, the company operates research and production facilities and maintains a portfolio covering veterinary testing, human testing, food safety testing, drug abuse testing, tumor and cardiac marker testing, and reproductive health testing. HEO states that it has more than 100 product types and serves customers in more than 100 countries and regions. Its quality management systems include ISO 9001 and ISO 13485, while its public certification information lists additional certifications and market-related approvals. The company provides OEM and ODM services and continues to develop rapid diagnostic products for international markets. More information about Hangzhou HEO Technology Co., Ltd. is available at [www.heolabs.com].
Address: Building 3, No. 2073 Jinchang Road, Yuhang District, Hangzhou, Zhejiang, China
Official Website: https://www.heolabs.com/
Betty Xu
Hangzhou HEO Technology Co., Ltd.
heo@heolabs.com
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
![]()
Media gallery